Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study

The Lancet Psychiatry

Volumn 4, Issue 7, 2017, Pages 547-553

  Tiihonen, Jari ^a,b   Tanskanen, Antti ^a,b,c   Hoti, Fabian ^d   Vattulainen, Pia ^d   Taipale, Heidi ^a,b   Mehtälä, Juha ^d   Lähteenvuo, Markku ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d EPID Research Oy   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; CLOZAPINE; LITHIUM; NEUROLEPTIC AGENT; QUETIAPINE;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FINLAND; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL MORTALITY; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MOOD DISORDER; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RELAPSE; RISK REDUCTION;

EID: 85020128999     PISSN: 22150366     EISSN: 22150374     Source Type: Journal    
DOI: 10.1016/S2215-0366(17)30134-7     Document Type: Article

References (25)

1. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386 (2015), 743–800.
2. Clarke, K, Mayo-Wilson, E, Kenny, J, Pilling, S, Can non-pharmacological interventions prevent relapse in adults who have recovered from depression? A systematic review and meta-analysis of randomised controlled trials. Clin Psychol Rev 39 (2015), 58–70.
3. Jarrett, RB, Minhajuddin, A, Gershenfeld, H, Friedman, ES, Thase, ME, Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo. JAMA Psychiatry 70 (2013), 1152–1160.
4. Borges, S, Chen, YF, Laughren, TP, et al. Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration. J Clin Psychiatry 75 (2014), 205–214.
5. Hansen, R, Gaynes, B, Thieda, P, et al. Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants. Psychiatr Serv 59 (2008), 1121–1130.
6. Geddes, JR, Carney, SM, Davies, C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 361 (2003), 653–661.
7. Glue, P, Donovan, MR, Kolluri, S, Emir, B, Meta-analysis of relapse prevention antidepressant trials in depressive disorders. Aust NZ J Psychiatry 44 (2010), 697–705.
8. Bauer, M, Bschor, T, Kunz, D, Berghöfer, A, Ströhle, A, Müller-Oerlinghausen, B, Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression. Am J Psychiatry 157 (2000), 1429–1435.
9. Cipriani, A, Smith, KA, Burgess, S, Carney, S, Goodwin, G, Geddes, J, Lithium versus antidepressants in the long-term treatment of unipolar affective disorder. Cochrane Database Syst Rev, 4, 2006 CD003492.
10. Tuori, T, Psykiatrian asennemuutos Suomessa. Suuntaaja 1 (2011), 1–4 (in Finnish).
11. Bschor, T, Bauer, M, Adli, M, Chronic and treatment resistant depression: diagnosis and stepwise therapy. Dtsch Arztebl Int 111 (2014), 766–775.
12. Crossley, NA, Bauer, M, Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials. J Clin Psychiatry 68 (2007), 935–940.
13. Connolly, KR, Thase, ME, If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies. Drugs 71 (2011), 43–64.
14. Tundo, A, de Filippis, R, Proietti, L, Pharmacologic approaches to treatment resistant depression: evidences and personal experience. World J Psychiatry 5 (2015), 330–341.
15. Tiihonen, J, Wahlbeck, K, Lönnqvist, J, et al. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study. BMJ, 333, 2006, 224.
16. Tiihonen, J, Lönnqvist, J, Wahlbeck, K, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 374 (2009), 620–627.
17. Tiihonen, J, Haukka, J, Taylor, M, Haddad, PM, Patel, MX, Korhonen, P, A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. Am J Psychiatry 168 (2011), 603–609.
18. Tiihonen, J, Suokas, JT, Suvisaari, JM, Haukka, J, Korhonen, P, Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia. Arch Gen Psychiatry 69 (2012), 476–483.
19. Tanskanen, A, Taipale, H, Koponen, M, et al. From prescription drug purchases to drug use periods—a second generation method (PRE2DUP). BMC Med Inform Decis Mak, 15, 2015, 21.
20. Taipale, H, Tanskanen, A, Koponen, M, Tolppanen, AM, Tiihonen, J, Hartikainen, S, Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons. Clin Epidemiol 8 (2016), 363–371.
21. Leucht, S, Hierl, S, Kissling, W, Dold, M, Davis, JM, Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses. Br J Psychiatry 200 (2012), 97–106.
22. Kessing, LV, Søndergård, L, Forman, JL, Andersen, PK, Lithium treatment and risk of dementia. Arch Gen Psychiatry 65 (2008), 1331–1335.
23. Nunes, PV, Forlenza, OV, Gattaz, WF, Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder. Br J Psychiatry 190 (2007), 359–360.
24. Gerhard, T, Devanand, DP, Huang, C, Crystal, S, Olfson, M, Lithium treatment and risk for dementia in adults with bipolar disorder: population-based cohort study. Br J Psychiatry 207 (2015), 46–51.
25. Huang, RY, Hsieh, KP, Huang, WW, Yang, YH, Use of lithium and cancer risk in patients with bipolar disorder: population-based cohort study. Br J Psychiatry 209 (2016), 393–399.